Document is current
Any future updates will be listed below
-
Authors
Wu, Xixi
Qiao, Xu
Xie, Yudi
Yang, Qingyan
An, Wenting
Xia, Lingfeng
Li, Jiatao
Lu, Xiao
-
Funding
Funding for this research was provided by:
National Key Research and Development Program of China (No. 2022YFC2405605, No. 2022YFC2405605, No. 2022YFC2405605, No. 2022YFC2405605, No. 2022YFC2405605, No. 2022YFC2405605, No. 2022YFC2405605, No. 2022YFC2405605)
Jiangsu Provincial Key Research and Development Program (BE2022160)
- License Information
-
More Information
Article History
Received: 3 December 2024
Accepted: 24 February 2025
First Online: 7 March 2025
Declarations
:
: The study was registered on the Chinese Clinical Trial Registry with the unique identification number ChiCTR1800019783, and it was approved by the ethics council of Nanjing Medical University’s First Affiliated Hospital (No. 2019-SR-310). The Ethics Committee of the first affiliated hospital of Nanjing Medical University approved all protocols. All participants provided written confirmed consent according to the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.
